Byrd K, Truong P. Bortezomib in the Treatment of Acquired von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance. kjm [Internet]. 2014 Nov. 6 [cited 2024 May 3];7(4):167-70. Available from: https://journals.ku.edu/kjm/article/view/11507